The Cell & Gene Therapy manufacturing Services market is driven by increasing investments in advanced therapies, rising ...

Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, and Charles River Laboratories (Charles River), a global industry-leading drug discovery, preclinical ...

Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

The technique is called in vivo CAR-M therapy. "The nomination of the two autoimmune targets is a significant milestone in ...

GC Therapeutics, Inc. (GCTx), announced its launch today to scale and unlock the next generation of cell therapy. Invented and developed by a world-class team of scientists in the lab of professor ...

Advancements in cell and gene therapy have been driven by improved insights into the human immune system and a better ...

Cryopreservation – freezing CGT biological materials at ultralow temperatures – helps minimize material loss of function during product shipment and storage, which occur before therapies are delivered ...

There's new hope for people with sickle cell disease which affects mainly African Americans. It's gene therapy research at ...

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...